Drug Utilization Study for Olodaterol
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Olodaterol (Primary) ; Indacaterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 02 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 01 Mar 2017 Status changed from not yet recruiting to recruiting.
- 23 Feb 2017 Planned number of patients changed from 2000 to 20000.